default author photo

Eui-Cheol Shin

Korea Advanced Institute of Science and Technology (KAIST) - Graduate School of Medical Science and Engineering

SCHOLARLY PAPERS

1

DOWNLOADS

124

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase I Study of Ex Vivo-Expanded Allogeneic Natural Killer Cells (MG4101) with Rituximab in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Number of pages: 28 Posted: 03 May 2022
University of Ulsan - Asan Medical Center, Seoul National University - Department of Internal Medicine, GC Cell - Cell Therapy Research Center, GC Cell - Cell Therapy Research Center, Korea Advanced Institute of Science and Technology (KAIST) - Graduate School of Medical Science and Engineering, GC Cell - Cell Therapy Research Center and Sungkyunkwan University - Samsung Medical Center
Downloads 124 (580,653)

Abstract:

Loading...

ex vivo-expanded allogeneic natural killer cell, rituximab, relapsed/refractory B-cell non-Hodgkin lymphoma, MG4101